Leadership TeamVeronique Boulanger VP of Chemistry, Manufacturing, and Controls (CMC) Veronique Boulanger joined Milestone in January, 2017 and as Vice President of Chemistry, Manufacturing, and Controls (CMC), ensures that every stage of drug manufacturing is aligned with the highest standards…
Mr. Nelson has served as Milestone’s Vice President of Program Management since 2018. He has over 15 years of experience in the pharmaceutical and biotech field, working primarily in project management, clinical operations, regulatory affairs, and public finance.
Leadership TeamLorenz Muller Chief Commercial Officer Mr. Muller has served as Milestone’s Chief Commercial Officer since October 2017. Mr. Muller has almost 30 years of pharmaceutical industry experience where he served startup-to-large multinational companies. Prior to joining Milestone, he led…
Leadership TeamDavid B. Bharucha Chief Medical Officer Dr. Bharucha joined Milestone Pharmaceuticals as Chief Medical Officer in February 2022. He is a cardiac electrophysiologist who brings considerable global drug-development and clinical experience in cardiovascular and multiple other therapeutic areas. Prior…
Mr. Hasija joined Milestone as Chief Financial Officer in September 2019. Prior to Milestone Pharmaceuticals, Mr. Hasija served as Chief Financial Officer and Chief Business Officer at Fulcrum Therapeutics, a publicly traded, clinical-stage biopharmaceutical company focused on developing therapies for genetically defined rare diseases.
Mr. Oliveto has served as Milestone’s President and Chief Executive Officer since March 2017 and as a member of Milestone’s board of directors since July 2017. Prior to Milestone Pharmaceuticals, Mr. Oliveto was President, CEO and a Director of Chelsea Therapeutics International, Ltd.
.png){kind=small}